Structure, function and pharmacology of human itch GPCRs
- Nature. 2021 Dec;600(7887):170-175. doi: 10.1038/s41586-021-04126-6.
- 1. Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
- 2. Department of Pharmaceutical Sciences, University of California San Francisco, School of Medicine, San Francisco, CA, USA.
- 3. Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences, Oncological Sciences and Neuroscience, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 4. Department of Physiology, University of California, San Francisco, San Francisco, CA, USA.
- 5. Department of Pathology, Duke University Medical Center, Durham, NC, USA.
- 6. Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA.
- 7. Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, USA.
- 8. Howard Hughes Medical Institute, San Francisco, CA, USA.
- 9. Program in Emerging Infectious Diseases, Duke-National University of Singapore, Singapore, Singapore.
- 10. Department of Pharmaceutical Sciences, University of California San Francisco, School of Medicine, San Francisco, CA, USA. [email protected].
- 11. Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA. [email protected].
- 12. Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA. [email protected].
- # Contributed equally.
The MRGPRX family of receptors (MRGPRX1-4) is a family of mas-related G-protein-coupled receptors that have evolved relatively recently1. Of these, MRGPRX2 and MRGPRX4 are key physiological and pathological mediators of itch and related mast cell-mediated hypersensitivity reactions2-5. MRGPRX2 couples to both Gi and Gq in mast cells6. Here we describe agonist-stabilized structures of MRGPRX2 coupled to Gi1 and Gq in ternary complexes with the endogenous peptide cortistatin-14 and with a synthetic agonist probe, respectively, and the development of potent antagonist probes for MRGPRX2. We also describe a specific MRGPRX4 agonist and the structure of this agonist in a complex with MRGPRX4 and Gq. Together, these findings should accelerate the structure-guided discovery of therapeutic agents for pain, itch and mast cell-mediated hypersensitivity.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Others